|
Soria-Juan B, Escacena N, Capilla-Gonzalez V, Aguilera Y, Llanos L, Tejedo JR, Bedoya FJ, Juan V, De la Cuesta A, Ruiz-Salmeron R, Andreu E, Grochowicz L, Prosper F, Sanchez-Guijo F, Lozano FS, Miralles M, Del Rio-Sola L, Castellanos G, Moraleda JM, Sackstein R, Garcia-Arranz M, Garcia-Olmo D, Martin F, Hmadcha A, Soria B; Collaborative Working Group "Noma Project Team". Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus. Front Immunol. 2020 Sep 2;11:2029. doi: 10.3389/fimmu.2020.02029. eCollection 2020. PubMed PMID: 32983148; PubMed Central PMCID: PMC7492973.
AÑO: 2020; IF: 7.561
|
32983148
|
Mirones I, Moreno L, Patino-Garcia A, Lizeaga G, Moraleda JM, Toribio ML, Perez-Martinez A; Grupo de Inmunoterapia y Terapias Avanzadas de la Sociedad Espanola de Hematologia y Oncologia Pediatricas; Grupo de Inmunoterapia y Terapias Avanzadas de la Sociedad Espanola de Hematologia y Oncologia Pediatricas. [Immunotherapy with CAR-T cells in paediatric haematology-oncology]. An Pediatr (Engl Ed). 2020 Jul;93(1):59.e1-59.e10. doi: 10.1016/j.anpedi.2019.12.014. Epub 2020 Feb 24. Spanish. PubMed PMID: 32107177.
AÑO: 2020; IF: 1.5
|
|
Paiva B, Puig N, Cedena MT, Rosinol L, Cordon L, Vidriales MB, Burgos L, Flores-Montero J, Sanoja-Flores L, Lopez-Anglada L, Maldonado R, de la Cruz J, Gutierrez NC, Calasanz MJ, Martin-Ramos ML, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Blanchard MJ, Rios R, Martin J, Martinez-Martinez R, Sureda A, Hernandez MT, de la Rubia J, Krsnik I, Moraleda JM, Palomera L, Bargay J, Van Dongen JJM, Orfao A, Mateos MV, Blade J, San-Miguel JF, Lahuerta JJ; GEM (Grupo Espanol de Mieloma)/PETHEMA (Programa Para el Estudio de la Terapeutica en Hemopatias Malignas) Cooperative Study Group. Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma. J Clin Oncol. 2020 Mar 10;38(8):784-792. doi: 10.1200/JCO.19.01231. Epub 2019 Nov 26. PubMed PMID: 31770060.
AÑO: 2020; IF: 44.544
|
|
Richardson E, Carlo-Stella C, Jara R, Vlodavsky I, Iacobelli M, Fareed J, Mo C, O'Gorman P, Yanik G, Palomo M, Diaz-Ricart M, Moraleda JM; DEFACOVID Study Group. Response to Maccio et al, "Multifactorial pathogenesis of COVID-19-related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?". J Thromb Haemost. 2020 Nov;18(11):3111-3113. doi: 10.1111/jth.15088. No abstract available. PubMed PMID: 32860297; PubMed Central PMCID: PMC9770769.
AÑO: 2020
|
|
Sanchez-Guijo F, Garcia-Olmo D, Prosper F, Martinez S, Zapata A, Fernandez-Aviles F, Toledo-Aral JJ, Torres M, Farinas I, Badimon L, Labandeira-Garcia JL, Garcia-Sancho J, Moraleda JM; TerCel. Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research. Cytotherapy. 2020 Jan;22(1):1-5. doi: 10.1016/j.jcyt.2019.11.001. Epub 2019 Dec 19. PubMed PMID: 31866320.
AÑO: 2020; IF: 5.414
|